Madrigal Pharmaceuticals, Inc. (LON:0JXI)
London · Delayed Price · Currency is GBP · Price in USD 530.89
+12.23 (2.36%)
At close: Nov 14, 2025
Madrigal Pharmaceuticals Market Cap
Madrigal Pharmaceuticals has a market cap or net worth of 9.13 billion as of November 14, 2025. Its market cap has increased by 153.33% in one year.
Market Cap
9.13B
Enterprise Value
8.55B
Revenue
550.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
530.89
Market Cap Chart
Since July 25, 2016, Madrigal Pharmaceuticals's market cap has increased from 87.68M to 9.13B, an increase of 10,316.36%. That is a compound annual growth rate of 64.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 9.13B | 69.89% |
| Dec 31, 2024 | 5.38B | 49.90% |
| Dec 29, 2023 | 3.59B | -16.56% |
| Dec 30, 2022 | 4.30B | 301.70% |
| Dec 31, 2021 | 1.07B | -15.04% |
| Dec 31, 2020 | 1.26B | 18.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.84B |
| HSBC Holdings | 189.64B |
| Shell | 164.85B |
| Unilever | 111.29B |
| Rolls-Royce Holdings | 93.03B |
| Rio Tinto Group | 91.98B |
| British American Tobacco p.l.c. | 88.61B |
| GSK plc | 71.68B |